Status:
COMPLETED
Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Hepatocellular Cancer
Gastrointestinal Cancer
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
According to the total population of cancer patients, hepatocellular carcinoma (HCC) and colorectal cancer (CRC), two of gastroenterological cancers are involved in the most acquired five cancers. Col...
Detailed Description
According to the total population of cancer patients, hepatocellular carcinoma (HCC) and colorectal cancer (CRC), two of gastroenterological cancers are involved in the most acquired five cancers. Col...
Eligibility Criteria
Inclusion
- Clinical diagnosis of gastrointestinal cancer
- Must have the will to receive acupuncture
Exclusion
- Clinical diagnosis of Late cancer
- History of having bad reflect in acupuncture
- Coagulopathy
Key Trial Info
Start Date :
August 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04692454
Start Date
August 31 2020
End Date
November 30 2020
Last Update
December 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WanFangH
Taipei, Taiwan, 116